Atossa Therapeutics
ATOS
#9966
Rank
โ‚น3.16 B
Marketcap
โ‚น367.38
Share price
-15.98%
Change (1 day)
442.56%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): -โ‚น21.52

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น22.68. In 2024 the company made an earnings per share (EPS) of -โ‚น18.14 an increase over its 2023 EPS that were of -โ‚น21.77.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น21.5218.63%
2024-โ‚น18.14-16.67%
2023-โ‚น21.7714.29%
2022-โ‚น19.0516.67%
2021-โ‚น16.33-90.86%
2020-โ‚น178.70-2.96%
2019-โ‚น184.15-63.09%
2018-โ‚น498.92-49.63%
2017-โ‚น990.58-57.87%
2016-โ‚น2,351-74.01%
2015-โ‚น9,046-9.18%
2014-โ‚น9,960-12.86%
2013-โ‚น11,43070.73%
2012-โ‚น6,69534.08%
2011-โ‚น4,993263.47%
2010-โ‚น1,374

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,010-4,554.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น783.75-3,556.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น929.80-4,200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น79.83 252.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚น19.05-16.00%๐Ÿ‡บ๐Ÿ‡ธ USA